Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):38–46. doi: 10.1097/QAI.0000000000000803

Table 2.

Demographic and Baseline Characteristics by Study Group

Total
N=42
n (%)
COMB*
N=22
n (%)
TAU**
N=20
n (%)
p-value
Age (years)
  Mean (SD) [range 18 – 24] 21.5 (1.6) 21.5 (1.6) 21.5 (1.6) 0.98
Gender
  Male 29 (69.0) 21 (95.5) 8 (40.0) < 0.001
Ethnicity
  Hispanic or Latino 9 (21.4) 3 (13.6) 6 (30.0) 0.27
Race
  Black or African American 35 (83.3) 19 (86.4) 16 (80.0) 0.64
Mode of HIV transmission
  Perinatal transmission 4 (9.5) 1 (4.5) 3 (15.0) < 0.001
  High-risk heterosexual contact 5 (11.9) 1 (4.5) 4 (20.0)
  Male-to-male sexual contact 28 (66.7) 20 (90.9) 8 (40.0)
  Presumed heterosexual contact 5 (11.9) 0 (0.0) 5 (25.0)
Baseline CD4 count - categorical
< 200 6 (14.3) 4 (18.2) 2 (10.0) 0.93
  200 – 350 6 (14.3) 3 (13.6) 3 (15.0)
  350 – 500 10 (23.8) 5 (22.7) 5 (25.0)
  ≥ 500 20 (47.6) 10 (45.5) 10 (50.0)
Log 10 Viral Load
  Mean (SD) 2.9 (1.4) 2.7 (1.3) 3.1 (1.5) 0.33
Baseline Viral load - categorical
< 400 21 (50.0) 12 (54.5) 9 (45.0) 0.93
  400 – 9,999 1 (2.4) 1 (4.5) 0 (0.0)
  1,000 – 9,999 9 (21.4) 4 (18.2) 5 (25.0)
  10,000 – 99,999 8 (19.0) 4 (18.2) 4 (20.0)
  ≥ 100,000 3 (7.1) 1 (4.5) 2 (10.0)
Did you drink alcohol (beer, wine or wine coolers, etc.) in the past 3 months?
  Yes 31 (86.1) 16 (84.2) 15 (88.2) 1.00
Have you smoked marijuana, other than just trying a few puffs, in the past 3 months?
  Yes 20 (55.6) 11 (57.9) 9 (52.9) 1.00
Have you used any other king of drug in the past 3 months?
  Yes 3 (8.3) 2 (10.5) 1 (5.9) 1.00
*

COMB = combined manualized CBT and medication management algorithm

**

TAU = treatment as usual